REGENXBIO Provides Year-End 2015 Corporate Update
Jan 07, 2016 13:00 pm UTC| Business
Company begins 2016 in strong financial position, on track to advance multiple lead gene therapy product candidate programs into clinicRGX-501 IND for treatment of homozygous familial hypercholesterolemia is activeFive new...
Prothena Announces Pricing of Public Offering of 2,250,000 Ordinary Shares
Jan 07, 2016 13:00 pm UTC| Business
DUBLIN, Ireland, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein...
KemPharm Added to NASDAQ Biotechnology Index
Jan 07, 2016 13:00 pm UTC| Business
CORALVILLE, Iowa , Jan. 07, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that...
BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase
Jan 07, 2016 13:00 pm UTC| Business
NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase III immuno-oncology...
Jan 07, 2016 13:00 pm UTC| Business
Boca Raton, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Bioceuticals are the nutritional building blocks necessary for making new DNA and RNA, which have to be obtained from our diets, but are found in low...
Cardica and Intuitive Surgical Amend License Agreement
Jan 07, 2016 13:00 pm UTC| Business
REDWOOD CITY, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Cardica, Inc. (Nasdaq:CRDC) today announced that the company has amended its license agreement, initially signed in August 2010, with Intuitive Surgical, Inc....
Jan 07, 2016 13:00 pm UTC| Business
Pivotal Trial of Cynapsus’ Under-the-Tongue Apomorphine Formulation Will Include Technology-Enabled Sub-Study to Gather and Analyze Objective Patient Data on Disease Progression and Medication Effect Effort Builds on...